» Articles » PMID: 19492093

Significant Reduction of Antibiotic Use in the Community After a Nationwide Campaign in France, 2002-2007

Overview
Journal PLoS Med
Specialty General Medicine
Date 2009 Jun 4
PMID 19492093
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Overuse of antibiotics is the main force driving the emergence and dissemination of bacterial resistance in the community. France consumes more antibiotics and has the highest rate of beta-lactam resistance in Streptococcus pneumoniae than any other European country. In 2001, the government initiated "Keep Antibiotics Working"; the program's main component was a campaign entitled "Les antibiotiques c'est pas automatique" ("Antibiotics are not automatic") launched in 2002. We report the evaluation of this campaign by analyzing the evolution of outpatient antibiotic use in France 2000-2007, according to therapeutic class and geographic and age-group patterns.

Methods And Findings: This evaluation is based on 2000-2007 data, including 453,407,458 individual reimbursement data records and incidence of flu-like syndromes (FLSs). Data were obtained from the computerized French National Health Insurance database and provided by the French Sentinel Network. As compared to the preintervention period (2000-2002), the total number of antibiotic prescriptions per 100 inhabitants, adjusted for FLS frequency during the winter season, changed by -26.5% (95% confidence interval [CI] -33.5% to -19.6%) over 5 years. The decline occurred in all 22 regions of France and affected all antibiotic therapeutic classes except quinolones. The greatest decrease, -35.8% (95% CI -48.3% to -23.2%), was observed among young children aged 6-15 years. A significant change of -45% in the relationship between the incidence of flu-like syndromes and antibiotic prescriptions was observed.

Conclusions: The French national campaign was associated with a marked reduction of unnecessary antibiotic prescriptions, particularly in children. This study provides a useful method for assessing public-health strategies designed to reduce antibiotic use.

Citing Articles

"Know your medicines, know your health"-public perspectives on medicines and health awareness campaigns.

Alhomoud F, Alameer K, Almousa Z, Almatar M, Alzlaiq W, Alhomoud F Front Public Health. 2025; 13:1541185.

PMID: 40027507 PMC: 11868082. DOI: 10.3389/fpubh.2025.1541185.


Impact evaluation of guidelines on antibiotic utilisation & appropriateness in Malaysian public primary care: an interrupted time series analysis.

Lim A, Ab Rahman N, Ong S, Mohamad Azman S, Mohd Rathi F, Ismail M J Pharm Policy Pract. 2024; 17(1):2355666.

PMID: 38845627 PMC: 11155422. DOI: 10.1080/20523211.2024.2355666.


The antibiotic knowledge, attitudes and behaviours of patients purchasing antibiotics with prescription in Russia: a qualitative, comparative analysis.

Rachina S, Zakharenkova P, Kozlov R, Palagin I, Shishkina K, Strelkova D JAC Antimicrob Resist. 2024; 6(2):dlae041.

PMID: 38523731 PMC: 10959511. DOI: 10.1093/jacamr/dlae041.


Antibiotic Resistance of in Nasopharyngeal Carriage of Children with Acute Otitis Media and in Middle Ear Fluid from Otorrhea.

Assad Z, Cohen R, Varon E, Levy C, Bechet S, Corrard F Antibiotics (Basel). 2023; 12(11).

PMID: 37998807 PMC: 10668799. DOI: 10.3390/antibiotics12111605.


Do clinical and communication skills scores on credentialing exams predict potentially inappropriate antibiotic prescribing?.

Tamblyn R, Moraga T, Girard N, Boulet J, Chan F, Habib B BMC Med Educ. 2023; 23(1):821.

PMID: 37915014 PMC: 10621187. DOI: 10.1186/s12909-023-04817-w.


References
1.
Belongia E, Knobloch M, Kieke B, Davis J, Janette C, Besser R . Impact of statewide program to promote appropriate antimicrobial drug use. Emerg Infect Dis. 2005; 11(6):912-20. PMC: 3367605. DOI: 10.3201/eid1106.050118. View

2.
Harris A, Samore M, Lipsitch M, Kaye K, Perencevich E, Carmeli Y . Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis. 2002; 34(12):1558-63. DOI: 10.1086/340533. View

3.
Cars O, Molstad S, Melander A . Variation in antibiotic use in the European Union. Lancet. 2001; 357(9271):1851-3. DOI: 10.1016/S0140-6736(00)04972-2. View

4.
Samore M, Lipsitch M, Alder S, Haddadin B, Stoddard G, Williamson J . Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. Am J Epidemiol. 2005; 163(2):160-70. DOI: 10.1093/aje/kwj021. View

5.
Sommet A, Sermet C, Boelle P, Tafflet M, Bernede C, Guillemot D . No significant decrease in antibiotic use from 1992 to 2000, in the French community. J Antimicrob Chemother. 2004; 54(2):524-8. DOI: 10.1093/jac/dkh342. View